ClinicalTrials.Veeva

Menu

A Study of the Effect of Plasmaexchange in Patients With Acute Liver Failure

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Acute Liver Failure

Treatments

Procedure: Standard medical treatment
Procedure: High volume plasma exchange

Study type

Interventional

Funder types

Other

Identifiers

NCT00950508
EMPET-001

Details and patient eligibility

About

The aim of this study is to examine if high-volume plasma exchange has a positive effect on mortality in patients with acute liver failure.

Enrollment

183 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with acute liver failure in encephalopathy grade 2-4

Exclusion criteria

  • alcoholic hepatitis
  • primary non function liver graft or graft dysfunction
  • known chronic liver disease
  • known malignancies
  • clinical suspicion of brain death

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

183 participants in 2 patient groups, including a placebo group

High volume plasma exchange
Active Comparator group
Description:
3 successive plasma exchanges over 3 days
Treatment:
Procedure: High volume plasma exchange
Procedure: Standard medical treatment
Standard medical treatment
Placebo Comparator group
Treatment:
Procedure: Standard medical treatment

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems